Perspective Therapeutics Statistics
Total Valuation
CATX has a market cap or net worth of $158.47 million. The enterprise value is -$59.94 million.
Important Dates
The last earnings date was Wednesday, March 26, 2025, after market close.
| Earnings Date | Mar 26, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CATX has 74.05 million shares outstanding. The number of shares has increased by 140.72% in one year.
| Current Share Class | 74.05M |
| Shares Outstanding | 74.05M |
| Shares Change (YoY) | +140.72% |
| Shares Change (QoQ) | +0.27% |
| Owned by Insiders (%) | 4.68% |
| Owned by Institutions (%) | 64.90% |
| Float | 54.56M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 97.48 |
| Forward PS | 246.29 |
| PB Ratio | 0.53 |
| P/TBV Ratio | 0.68 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 12.68, with a Debt / Equity ratio of 0.01.
| Current Ratio | 12.68 |
| Quick Ratio | 12.53 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1,391.60 |
Financial Efficiency
Return on equity (ROE) is -42.82% and return on invested capital (ROIC) is -22.42%.
| Return on Equity (ROE) | -42.82% |
| Return on Assets (ROA) | -19.02% |
| Return on Invested Capital (ROIC) | -22.42% |
| Return on Capital Employed (ROCE) | -20.69% |
| Revenue Per Employee | $12,218 |
| Profits Per Employee | -$666,210 |
| Employee Count | 140 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -2.10M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -81.67% in the last 52 weeks. The beta is 1.20, so CATX's price volatility has been higher than the market average.
| Beta (5Y) | 1.20 |
| 52-Week Price Change | -81.67% |
| 50-Day Moving Average | 2.94 |
| 200-Day Moving Average | 8.46 |
| Relative Strength Index (RSI) | 33.42 |
| Average Volume (20 Days) | 561,955 |
Short Selling Information
The latest short interest is 5.94 million, so 8.02% of the outstanding shares have been sold short.
| Short Interest | 5.94M |
| Short Previous Month | 5.48M |
| Short % of Shares Out | 8.02% |
| Short % of Float | 10.89% |
| Short Ratio (days to cover) | 10.36 |
Income Statement
In the last 12 months, CATX had revenue of $1.45 million and -$79.28 million in losses. Loss per share was -$1.23.
| Revenue | 1.45M |
| Gross Profit | -37.98M |
| Operating Income | -66.80M |
| Pretax Income | -50.57M |
| Net Income | -79.28M |
| EBITDA | -64.50M |
| EBIT | -66.80M |
| Loss Per Share | -$1.23 |
Full Income StatementBalance Sheet
The company has $226.92 million in cash and $4.06 million in debt, giving a net cash position of $222.85 million or $3.01 per share.
| Cash & Cash Equivalents | 226.92M |
| Total Debt | 4.06M |
| Net Cash | 222.85M |
| Net Cash Per Share | $3.01 |
| Equity (Book Value) | 290.67M |
| Book Value Per Share | 4.11 |
| Working Capital | 212.93M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$18.29 million and capital expenditures -$54.41 million, giving a free cash flow of -$72.71 million.
| Operating Cash Flow | -18.29M |
| Capital Expenditures | -54.41M |
| Free Cash Flow | -72.71M |
| FCF Per Share | -$0.98 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -4,594.02% |
| Pretax Margin | -5,531.43% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CATX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -140.72% |
| Shareholder Yield | -140.72% |
| Earnings Yield | -48.66% |
| FCF Yield | -44.63% |
Analyst Forecast
The average price target for CATX is $15.30, which is 614.95% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $15.30 |
| Price Target Difference | 614.95% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (5Y) | 152.73% |
| EPS Growth Forecast (5Y) | 2.27% |
Stock ForecastsStock Splits
The last stock split was on June 17, 2024. It was a reverse split with a ratio of 0.1:1.
| Last Split Date | Jun 17, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.1:1 |
Scores
CATX has an Altman Z-Score of 7.42 and a Piotroski F-Score of 3.
| Altman Z-Score | 7.42 |
| Piotroski F-Score | 3 |